VYGR
Voyager Therapeutics Inc
2.80$
-2.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 159.7% | 297.1% | 614.3% | 851.9% | 114.7% | 63.6% | 197.2% | 15.1% | 36.9% | 5.9% | 327.6% | |
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 36.4% | 100.0% | 100.0% | 63.1% | 100.0% | -227.6% | |
| – | – | 159.7% | 297.1% | 614.3% | 851.9% | 114.7% | 63.6% | 197.2% | 148.5% | 36.9% | 159.2% | 333.6% | |
| – | – | 57.2% | 93.3% | 194.8% | 443.7% | 34.8% | 20.4% | 99.5% | 75.7% | 14.3% | 44.9% | 90.3% | |
| – | – | 216.8% | 390.4% | 809.1% | 1,295.6% | 149.5% | 20.4% | 296.8% | 224.3% | 14.3% | 204.1% | 98.9% | |
| – | – | -116.8% | -290.4% | -709.1% | -1,195.6% | -49.5% | 16.0% | -196.8% | -124.3% | 48.8% | -104.1% | -326.6% | |
| – | – | 1.9% | 6.9% | 0.0% | 0.0% | 0.0% | 0.0% | 1.0% | 4.4% | – | – | – | |
| – | – | -171.2% | -282.3% | -697.6% | -1,161.1% | -41.8% | 21.5% | -190.3% | -113.4% | 53.5% | -80.4% | -296.2% | |
| – | – | -3.5% | 0.4% | -15.7% | -2.4% | -2.6% | -1.0% | -13.8% | 0.0% | 0.6% | 0.8% | 0.4% | |
| – | – | -171.2% | -282.7% | -697.6% | -1,158.8% | -39.1% | 21.5% | -176.5% | -113.4% | 52.9% | -81.3% | -296.5% | |
| – | – | -113.4% | -286.1% | -693.3% | -1,167.8% | -46.9% | 18.2% | -183.0% | -109.1% | 55.3% | -74.5% | -286.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.